Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Clayton

Showing results (391-400 of 407) with videos related to

Pageof 41
Sort By:
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Stem Cell Reports|November 23, 2023
Deriving early single-rosette brain organoids from human pluripotent stem cellsAndrew M Tidball, Wei Niu, Qianyi Ma, et al.
Microsystems & Nanoengineering|September 27, 2021
A monolithic single-chip point-of-care platform for metabolomic prostate cancer detectionValerio F Annese, Samadhan B Patil, Chunxiao Hu, et al.
Science (New York, N.Y.)|August 29, 2020
A synthetic synaptic organizer protein restores glutamatergic neuronal circuitsKunimichi Suzuki, Jonathan Elegheert, Inseon Song, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm studyM Luu, P Vabres, H Devilliers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphomaA J Davies, A Z S Rohatiner, S Howell, et al.
Journal of Medical Genetics|August 30, 2008
Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patientsC Zweier, H Sticht, E K Bijlsma, et al.
Chemistry & Biology|January 21, 2014
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitroChristina I Schroeder, Joakim E Swedberg, Jane M Withka, et al.
American Journal of Human Genetics|June 18, 2005
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndromeD Beysen, J Raes, B P Leroy, et al.
Neuropathology and Applied Neurobiology|September 8, 2020
Heterozygous CAPN3 missense variants causing autosomal-dominant calpainopathy in seven unrelated familiesL González-Mera, G Ravenscroft, M Cabrera-Serrano, et al.
Pageof 41

Showing results (391-400 of 407) with videos related to

Sort By:
Pageof 41
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Stem Cell Reports|November 23, 2023
Deriving early single-rosette brain organoids from human pluripotent stem cellsAndrew M Tidball, Wei Niu, Qianyi Ma, et al.
Microsystems & Nanoengineering|September 27, 2021
A monolithic single-chip point-of-care platform for metabolomic prostate cancer detectionValerio F Annese, Samadhan B Patil, Chunxiao Hu, et al.
Science (New York, N.Y.)|August 29, 2020
A synthetic synaptic organizer protein restores glutamatergic neuronal circuitsKunimichi Suzuki, Jonathan Elegheert, Inseon Song, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm studyM Luu, P Vabres, H Devilliers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphomaA J Davies, A Z S Rohatiner, S Howell, et al.
Journal of Medical Genetics|August 30, 2008
Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patientsC Zweier, H Sticht, E K Bijlsma, et al.
Chemistry & Biology|January 21, 2014
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitroChristina I Schroeder, Joakim E Swedberg, Jane M Withka, et al.
American Journal of Human Genetics|June 18, 2005
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndromeD Beysen, J Raes, B P Leroy, et al.
Neuropathology and Applied Neurobiology|September 8, 2020
Heterozygous CAPN3 missense variants causing autosomal-dominant calpainopathy in seven unrelated familiesL González-Mera, G Ravenscroft, M Cabrera-Serrano, et al.
Pageof 41